
    Original Text: A malignancy (other than the one treated in this study) which has a >= 30% probability of recurrence within 24 months (except for adequately treated non-melanoma skin cancer, curatively treated in-situ cancer of the cervix or Ta urothelial carcinomas)
    Disease/Condition: Malignancy
    Procedure: None
    Drug: None
    Biomarker: None
    Computable Rule: "Malignancy" is True AND ">= 30%" is True

Criterion:
    Patients with metastatic breast cancer who have progressed on at least two chemotherapeutic regimens for advanced disease

Output:
    Original Text: Patients with metastatic breast cancer who have progressed on at least two chemotherapeutic regimens for advanced disease
    Disease/Condition: Metastatic Breast Cancer
    Procedure: None
    Drug: None
    Biomarker: None
    Computable Rule: "Metastatic Breast Cancer" is True AND "progressed on